122 related articles for article (PubMed ID: 38116957)
1. Radiation oncology for the rhinologist.
Levyn H; Yang F; Lee NY
Curr Opin Otolaryngol Head Neck Surg; 2024 Feb; 32(1):5-13. PubMed ID: 38116957
[TBL] [Abstract][Full Text] [Related]
2. Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma: A Randomized Clinical Trial.
Tang LL; Guo R; Zhang N; Deng B; Chen L; Cheng ZB; Huang J; Hu WH; Huang SH; Luo WJ; Liang JH; Zheng YM; Zhang F; Mao YP; Li WF; Zhou GQ; Liu X; Chen YP; Xu C; Lin L; Liu Q; Du XJ; Zhang Y; Sun Y; Ma J
JAMA; 2022 Aug; 328(8):728-736. PubMed ID: 35997729
[TBL] [Abstract][Full Text] [Related]
3. Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
Li X; Kitpanit S; Lee A; Mah D; Sine K; Sherman EJ; Dunn LA; Michel LS; Fetten J; Zakeri K; Yu Y; Chen L; Kang JJ; Gelblum DY; McBride SM; Tsai CJ; Riaz N; Lee NY
JAMA Netw Open; 2021 Jun; 4(6):e2113205. PubMed ID: 34143193
[TBL] [Abstract][Full Text] [Related]
4. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma.
Kong L; Hu J; Guan X; Gao J; Lu R; Lu JJ
J Cancer; 2016; 7(7):774-83. PubMed ID: 27162535
[TBL] [Abstract][Full Text] [Related]
6. Nasopharyngeal carcinoma in adults: treatment results after long-term follow-up with special reference to adjuvant interferon-beta in undifferentiated carcinomas.
Wolff HA; Rödel RM; Gunawan B; Overbeck T; Herrmann MK; Hennies S; Hille A; Vorwerk H; Matthias C; Hess CF; Christiansen H
J Cancer Res Clin Oncol; 2010 Jan; 136(1):89-97. PubMed ID: 19618214
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities.
Sun X; Su S; Chen C; Han F; Zhao C; Xiao W; Deng X; Huang S; Lin C; Lu T
Radiother Oncol; 2014 Mar; 110(3):398-403. PubMed ID: 24231245
[TBL] [Abstract][Full Text] [Related]
8. Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.
You R; Liu YP; Xie YL; Lin C; Duan CY; Chen DP; Pan Y; Qi B; Zou X; Guo L; Cao JY; Zhang YN; Wang ZQ; Liu YL; Ouyang YF; Wen K; Yang Q; Xie RQ; Li HF; Duan XT; Ding X; Peng L; Chen SY; Liang JL; Feng ZK; Xia TL; Xie RL; Jiang R; Gu CM; Liu RZ; Sun R; Yang X; Liu LZ; Ling L; Liu Q; Ng WT; Hua YJ; Huang PY; Chen MY
Lancet; 2023 Mar; 401(10380):917-927. PubMed ID: 36842439
[TBL] [Abstract][Full Text] [Related]
9. High-dose Intensity-modulated proton therapy versus Standard-dose Intensity-modulated RadIation therapy for esophageal squamous cell carcinoma (HI-SIRI): study protocol for a randomized controlled clinical trial.
Lertbutsayanukul C; Kitpanit S; Kannarunimit D; Chakkabat C; Oonsiri S; Thephamongkhol K; Puataweepong P; Katanyoo K; Sukhaboon J; Tovanabut C; Chongsathientham S; Treeratsapanich P; Soonthornrak J; Prayongrat A
Trials; 2022 Oct; 23(1):897. PubMed ID: 36273186
[TBL] [Abstract][Full Text] [Related]
10. A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity.
Lee AWM; Tung SY; Ng WT; Lee V; Ngan RKC; Choi HCW; Chan LLK; Siu LL; Ng AWY; Leung TW; Yiu HHY; O'Sullivan B; Chappell R
Cancer; 2017 Nov; 123(21):4147-4157. PubMed ID: 28662313
[TBL] [Abstract][Full Text] [Related]
11. Re-irradiation with Moderate Hypo-fractionation Using Intensity Modulated Photon or Proton Radiation Therapy in Locally Recurrent Squamous Cell Carcinoma of Nasopharynx.
Nam H; Ahn YC; Yang K; Oh D; Noh JM
Cancer Res Treat; 2022 Jan; 54(1):96-108. PubMed ID: 33781049
[TBL] [Abstract][Full Text] [Related]
12. Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy.
Huang TL; Chien CY; Tsai WL; Liao KC; Chou SY; Lin HC; Dean Luo S; Lee TF; Lee CH; Fang FM
Head Neck; 2016 Apr; 38 Suppl 1():E1026-32. PubMed ID: 26041548
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy.
Hua YJ; Han F; Lu LX; Mai HQ; Guo X; Hong MH; Lu TX; Zhao C
Eur J Cancer; 2012 Dec; 48(18):3422-8. PubMed ID: 22835782
[TBL] [Abstract][Full Text] [Related]
14. Outcomes after reirradiation for recurrent nasopharyngeal carcinoma: North American experience.
Karam I; Huang SH; McNiven A; Su J; Xu W; Waldron J; Bayley AJ; Kim J; Cho J; Ringash J; Hope A; Chen E; Chan B; Goldstein D; O'Sullivan B; Giuliani ME
Head Neck; 2016 Apr; 38 Suppl 1():E1102-9. PubMed ID: 26451876
[TBL] [Abstract][Full Text] [Related]
15. Proton pencil-beam scanning radiotherapy in the treatment of nasopharyngeal cancer: dosimetric parameters and 2-year results.
Jiří K; Vladimír V; Michal A; Matěj N; Silvia S; Pavel V; Kateřina D; Jana P; Barbora O; Eliška R; Petr L; Matěj P; Alexander G; Jozef R
Eur Arch Otorhinolaryngol; 2021 Mar; 278(3):763-769. PubMed ID: 32623508
[TBL] [Abstract][Full Text] [Related]
16. Lower-Neck Sparing Using Proton Therapy in Patients with Uninvolved Neck Nasopharyngeal Carcinoma: Is It Safe?
De Felice F; Vai A; Camarda AM; Iacovelli NA; Orlandi E
J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743368
[TBL] [Abstract][Full Text] [Related]
17. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial.
Yang H; Chen X; Lin S; Rong J; Yang M; Wen Q; Shang C; He L; Ren P; Xu S; Zhang J; Liu Q; Pang H; Shi X; Fan J; Sun X; Ma D; Tan B; Zhang T; Zhang L; Hu D; Du X; Zhang Y; Wen S; Zhang X; Wu J
Radiother Oncol; 2018 Jan; 126(1):37-42. PubMed ID: 28864073
[TBL] [Abstract][Full Text] [Related]
19. Preliminary results of a phase I/II study of simultaneous boost irradiation radiotherapy for locally advanced nasopharyngeal carcinoma.
Xiang L; Wang Y; Xu BQ; Wu JB; Xia YF
Asian Pac J Cancer Prev; 2013; 14(12):7569-76. PubMed ID: 24460335
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of intensity-modulated radiotherapy alone versus intensity-modulated radiotherapy plus chemotherapy for treatment of intermediate-risk nasopharyngeal carcinoma.
Aftab O; Liao S; Zhang R; Tang N; Luo M; Zhang B; Shahi S; Rai R; Ali J; Jiang W
Radiat Oncol; 2020 Mar; 15(1):66. PubMed ID: 32178698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]